Streetbeat News

Products Services

AMZN

AVGO

GOOGL

NVDA

Broadcom Inc. (NASDAQ:AVGO) is gaining traction in the AI market, challenging Nvidia Corporation (NASDAQ:NVDA). Broadcom's AI business is growing, with new customers like OpenAI and Bytedance, and it dominates the data center/AI Ethernet switching and routing chipset market. Despite this, Nvidia remains a strong competitor with a higher stock gain over the past year.

Portfolio Pulse from Benzinga Neuro

July 23, 2024 | 11:15 am

EVEX

Eve Air Mobility and Siemens Smart Infrastructure have signed a Memorandum of Understanding to evaluate the electrical infrastructure and energy management services needed for scalable eVTOL operations in the United States.

Portfolio Pulse from charles@benzinga.com

July 23, 2024 | 11:12 am

IRBT

iRobot has launched the Roomba Combo 10 Max Robot along with the AutoWash Dock, introducing new features and enhancements to its product lineup.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:11 am

AZN

EWC

AstraZeneca announced that Voydeya (danicopan tablets) has been approved in Canada as an add-on therapy to ravulizumab or eculizumab for adults with paroxysmal nocturnal hemoglobinuria (PNH) who have residual hemolytic anemia due to extravascular hemolysis (EVH).

Portfolio Pulse from charles@benzinga.com

July 23, 2024 | 11:10 am

BGNE

BeiGene has opened a new biologics manufacturing and clinical R&D facility in New Jersey, investing $800 million. This expansion is expected to enhance their capabilities in biologics production and clinical research.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:09 am

ALTR

Altair has entered into a Memorandum of Understanding (MoU) with the University of Nottingham to develop aerospace digital twin projects. This collaboration aims to advance digital twin technology in the aerospace sector.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:06 am

ABBV

GMAB

AbbVie announced that Canada's drug agency has issued a time-limited reimbursement recommendation for EPKINLY (Epcoritamab) for adult patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL). EPKINLY is co-developed by AbbVie and Genmab.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:05 am

GILT

Gilat Satellite Networks has secured over $9 million in cumulative orders from multiple satellite operators to expand global satellite communication networks.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:03 am

EYEN

Eyenovia has entered into a collaboration agreement with Senju Pharmaceutical to develop a potential new treatment for chronic dry eye disease. This partnership aims to leverage Eyenovia's microdose array print technology and Senju's expertise in ophthalmology.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:03 am

MRK

Merck announced that its prophylactic monoclonal antibody, Clesrovimab, for Respiratory Syncytial Virus (RSV) disease has met its primary safety and efficacy endpoints.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 10:52 am